Charles River Laboratories (CRL) Tops Q3 EPS by 36c ; Offers Guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $180.90 -2.22%
Revenue Growth %: -5.1%
Financial Fact:
Selling, general and administrative: 85.65M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -5.1%
Financial Fact:
Selling, general and administrative: 85.65M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.72, $0.36 better than the analyst estimate of $2.36. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1 billion.
GUIDANCE:
Charles River Laboratories sees FY2023 EPS of $10.50-$10.70, versus the consensus of $10.56.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
